Trials / Completed
CompletedNCT03606122
5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities
Evaluation of the Suitability of a 5-ALA Patch (PD P 506 A, Alacare®) in the Photodynamic Therapy (PDT) of Actinic Keratosis on the Upper Extremities
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- photonamic GmbH & Co. KG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the potential usefulness of photodynamic therapy with PD P 506 A in patients with actinic keratosis on the upper extremities for the first time.
Detailed description
Patients will receive a second PD P 506 A-PDT on all AK lesions 1-2 weeks after the first PDT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PD P 506 A | PD P 506 A is a dermal patch of 4 cm² in size loaded with 2 mg 5-ALA (as 5-ALA HCl) per cm² |
Timeline
- Start date
- 2018-07-12
- Primary completion
- 2019-07-16
- Completion
- 2019-07-16
- First posted
- 2018-07-30
- Last updated
- 2019-08-28
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03606122. Inclusion in this directory is not an endorsement.